The application of snake venom in anticancer drug discovery: an overview of the latest developments

Joana R da Silva1, Juliana Castro-Amorim1, Ashis K Mukherjee2

  • 1LAQV, REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto, Portugal.

PubMed
Abstract

Insights

Snake venom toxins show promise for targeted cancer therapy by selectively destroying cancer cells. Advances in biotechnology and AI are crucial to overcome challenges and refine these potent compounds for effective treatment.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Oncology

Background:

  • Snake venom contains potent toxins with therapeutic potential.
  • These toxins can selectively target and destroy cancer cells while sparing healthy cells.
  • Snake venom derivatives are being explored for treating various conditions, including cardiovascular diseases and cancer.

Purpose of the Study:

  • To review emerging trends in snake-derived targeted cancer therapies.
  • To examine the effects of snake venom toxins on cancer cell lines and their targeted hallmarks.
  • To highlight the role of artificial intelligence in accelerating snake venom-based cancer drug discovery.

Main Methods:

  • Extensive literature review of snake venom toxins and their effects on cancer cell lines.
  • Analysis of specific cancer hallmarks targeted by various venom toxins.
  • Exploration of artificial intelligence applications in snake venom-derived drug discovery.

Main Results:

  • Snake venom toxins demonstrate significant potential for selectively targeting and destroying cancer cells.
  • Specific toxins target distinct cancer hallmarks, indicating tailored therapeutic possibilities.
  • Artificial intelligence tools show promise in accelerating the discovery and development of these therapies.

Conclusions:

  • Snake venom toxins offer a promising avenue for targeted cancer therapy.
  • Challenges such as venom composition variability, ethical concerns, and delivery barriers need to be addressed.
  • Biotechnology, molecular engineering, and in silico methods are essential for refining venom-derived compounds and enhancing their therapeutic efficacy in cancer treatment.

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
325
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates...
147
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
483